News

Alcon (NYSE:ALC) shares fell 9% in premarket trading on Wednesday, after the Swiss-American pharmaceutical and medical device ...
Supplementing with B vitamins and the essential nutrient choline may help slow the progression of glaucoma, a new study in ...
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS ...
A nationwide recall of over 75,000 cases of eye care products, including artificial tears and ophthalmic gels, was announced ...
Press Release Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Several aqueous humor parameters ...
US President, Donald Trump, on Wednesday, told interim Syrian President Ahmed al-Sharaa that his order to lift sanctions on Syria is a major policy shift, describing it as an “honour”.White House ...
Before Trump announced his intentions to lift US sanctions on Syria yesterday, it had been designated a state sponsor of ...
The pharmaceutical testing lab BRS Analytical Service recalled products used to relieve dry and irritated eyes after ...
Over-the-counter ophthalmic products were voluntarily recalled due to a manufacturing deviation discovered during a U.S. Food ...
Explore Alcon Inc.'s Q1 2025 highlights: new product launches like Unity VCS & PanOptix Pro driving growth, resilient strategies, and updated sales guidance.
Ophthalmic products were voluntarily recalled due to a manufacturing deviation discovered during an FDA audit. See the list of products here.
Explore One of the Most Advanced Nootropic Supplements for Mental Clarity, Focus, and Brain Fog Relief - Backed by 28+ ...